Nifty
:
24834.85
Sensex
:
81332.72
428.75 (1.76%)
1292.92 (1.62%)
Nifty
Sensex
:
:
24834.85
81332.72
428.75 (1.76%)
1292.92 (1.62%)

Granules India Ltd.

Pharmaceuticals & Drugs - API

Rating :
59/99

BSE: 532482 | NSE: GRANULES

NSE BSE
526.00
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  518.95
  •  530.65
  •  511.55
  •  514.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3974182
  •  20801.67
  •  566.65
  •  287.70

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 13,656.27
  • 33.69
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 14,493.11
  • 0.27%
  • 4.26

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 38.87%
  • 4.06%
  • 18.78%
  • FII
  • DII
  • Others
  • 20.39%
  • 13.85%
  • 4.05%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.30
  • 11.64
  • 6.18

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.16
  • 10.26
  • 3.47

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.12
  • 5.51
  • -0.61

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.91
  • 16.48
  • 17.06

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.95
  • 3.15
  • 3.08

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.69
  • 10.81
  • 10.89

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
1,175.78
1,195.50
-1.65%
1,155.58
1,146.13
0.82%
1,189.49
1,150.73
3.37%
985.52
1,019.56
-3.34%
Expenses
920.08
967.38
-4.89%
905.10
914.83
-1.06%
976.51
907.83
7.57%
848.69
808.05
5.03%
EBITDA
255.70
228.12
12.09%
250.48
231.29
8.30%
212.97
242.91
-12.33%
136.82
211.50
-35.31%
EBIDTM
21.75%
19.08%
21.68%
20.18%
17.90%
21.11%
13.88%
20.74%
Other Income
1.87
3.38
-44.67%
0.65
0.95
-31.58%
1.53
4.79
-68.06%
0.35
4.67
-92.51%
Interest
28.76
18.80
52.98%
28.65
16.97
68.83%
25.96
13.22
96.37%
22.46
6.94
223.63%
Depreciation
53.18
48.71
9.18%
52.39
48.36
8.33%
52.52
44.06
19.20%
49.24
43.36
13.56%
PBT
175.64
163.99
7.10%
170.09
166.90
1.91%
136.02
190.41
-28.56%
65.47
165.87
-60.53%
Tax
45.99
44.38
3.63%
44.44
42.57
4.39%
33.91
45.32
-25.18%
17.58
38.30
-54.10%
PAT
129.65
119.60
8.40%
125.65
124.33
1.06%
102.12
145.09
-29.62%
47.89
127.57
-62.46%
PATM
11.03%
10.00%
10.87%
10.85%
8.58%
12.61%
4.86%
12.51%
EPS
5.35
4.94
8.30%
5.18
5.14
0.78%
4.21
5.84
-27.91%
1.98
5.14
-61.48%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
-
4,506.37
4,511.92
3,764.92
3,237.54
2,598.65
2,279.20
1,684.62
1,410.57
1,357.18
1,292.92
Net Sales Growth
-
-0.12%
19.84%
16.29%
24.59%
14.02%
35.29%
19.43%
3.93%
4.97%
 
Cost Of Goods Sold
-
2,021.25
2,307.28
1,883.64
1,391.28
1,280.93
1,255.56
896.32
679.63
725.03
746.95
Gross Profit
-
2,485.12
2,204.63
1,881.28
1,846.27
1,317.72
1,023.64
788.30
730.93
632.15
545.97
GP Margin
-
55.15%
48.86%
49.97%
57.03%
50.71%
44.91%
46.79%
51.82%
46.58%
42.23%
Total Expenditure
-
3,650.39
3,598.60
3,043.30
2,382.31
2,073.33
1,895.16
1,406.20
1,111.73
1,081.29
1,084.31
Power & Fuel Cost
-
100.64
95.69
74.66
68.85
59.74
57.67
48.22
38.67
34.97
45.73
% Of Sales
-
2.23%
2.12%
1.98%
2.13%
2.30%
2.53%
2.86%
2.74%
2.58%
3.54%
Employee Cost
-
550.24
420.35
366.44
324.29
259.04
209.82
165.21
140.19
117.57
106.96
% Of Sales
-
12.21%
9.32%
9.73%
10.02%
9.97%
9.21%
9.81%
9.94%
8.66%
8.27%
Manufacturing Exp.
-
408.01
273.93
298.74
228.39
177.94
157.62
120.84
88.60
66.97
50.89
% Of Sales
-
9.05%
6.07%
7.93%
7.05%
6.85%
6.92%
7.17%
6.28%
4.93%
3.94%
General & Admin Exp.
-
211.99
187.96
134.41
172.28
125.63
99.96
83.05
67.65
60.38
59.84
% Of Sales
-
4.70%
4.17%
3.57%
5.32%
4.83%
4.39%
4.93%
4.80%
4.45%
4.63%
Selling & Distn. Exp.
-
290.63
280.00
247.45
159.80
112.17
91.84
83.08
81.37
67.75
71.70
% Of Sales
-
6.45%
6.21%
6.57%
4.94%
4.32%
4.03%
4.93%
5.77%
4.99%
5.55%
Miscellaneous Exp.
-
67.62
33.38
37.96
37.42
57.88
22.69
9.49
15.61
8.62
71.70
% Of Sales
-
1.50%
0.74%
1.01%
1.16%
2.23%
1.00%
0.56%
1.11%
0.64%
0.17%
EBITDA
-
855.98
913.32
721.62
855.23
525.32
384.04
278.42
298.84
275.89
208.61
EBITDA Margin
-
18.99%
20.24%
19.17%
26.42%
20.22%
16.85%
16.53%
21.19%
20.33%
16.13%
Other Income
-
4.40
14.29
18.22
26.88
36.56
26.68
10.84
9.93
5.62
4.34
Interest
-
105.82
55.93
23.21
26.28
27.02
28.46
33.06
32.26
37.07
32.35
Depreciation
-
207.33
184.49
158.63
151.46
136.95
105.48
76.20
71.51
58.40
52.65
PBT
-
547.23
687.17
558.00
704.36
397.90
276.78
180.00
204.99
186.03
127.96
Tax
-
141.92
170.58
145.24
154.91
115.73
89.11
63.40
65.20
61.15
37.05
Tax Rate
-
25.93%
24.82%
26.03%
21.99%
27.19%
32.20%
35.22%
31.81%
32.87%
28.95%
PAT
-
405.31
516.60
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
PAT before Minority Interest
-
405.31
516.60
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
8.99%
11.45%
10.96%
16.97%
11.93%
8.23%
6.92%
9.91%
9.20%
7.03%
PAT Growth
-
-21.54%
25.16%
-24.88%
77.30%
65.14%
60.95%
-16.59%
11.93%
37.38%
 
EPS
-
16.72
21.31
17.03
22.67
12.79
7.74
4.81
5.77
5.15
3.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
3,225.54
2,834.91
2,586.54
2,173.27
1,843.72
1,529.47
1,304.18
903.60
661.60
431.16
Share Capital
24.24
24.20
24.80
24.77
25.42
25.42
25.38
22.87
21.67
20.43
Total Reserves
3,183.00
2,792.68
2,545.01
2,126.23
1,800.02
1,493.09
1,273.38
878.28
611.13
410.74
Non-Current Liabilities
176.04
254.73
282.83
366.30
485.98
552.63
488.19
187.99
246.62
356.52
Secured Loans
68.97
148.64
233.70
333.81
414.83
478.78
433.13
123.90
183.66
302.59
Unsecured Loans
0.00
0.00
0.00
0.00
6.69
0.00
0.00
0.34
0.55
0.62
Long Term Provisions
37.88
29.26
28.31
24.84
21.50
12.58
7.70
7.25
5.58
4.03
Current Liabilities
2,082.29
1,813.50
1,641.60
1,173.10
893.40
896.48
877.91
787.13
654.75
415.03
Trade Payables
749.53
782.13
638.61
541.05
356.88
323.48
274.35
215.98
181.10
187.63
Other Current Liabilities
261.08
193.19
200.85
194.25
153.16
113.60
69.84
93.43
79.21
88.98
Short Term Borrowings
1,054.24
810.88
765.58
409.27
371.69
454.21
525.10
473.83
392.85
124.97
Short Term Provisions
17.45
27.31
36.56
28.53
11.66
5.20
8.62
3.90
1.58
13.45
Total Liabilities
5,483.87
4,903.14
4,511.53
3,712.67
3,223.10
2,978.58
2,670.28
1,878.72
1,562.97
1,202.71
Net Block
2,095.62
1,910.92
1,541.17
1,332.00
1,203.97
944.25
776.73
644.34
559.94
616.55
Gross Block
3,351.81
2,981.22
2,461.77
2,145.15
1,875.23
1,472.94
1,199.63
983.66
822.98
843.76
Accumulated Depreciation
1,256.19
1,070.30
920.59
813.15
671.26
528.69
422.90
339.32
263.05
227.21
Non Current Assets
2,578.83
2,328.99
2,006.54
1,715.68
1,594.41
1,696.34
1,483.71
1,050.55
744.97
699.69
Capital Work in Progress
271.70
239.39
356.23
239.08
294.20
495.95
514.52
267.43
76.56
62.03
Non Current Investment
21.52
21.21
19.67
18.99
19.34
210.42
156.56
108.23
70.11
0.19
Long Term Loans & Adv.
190.00
157.47
89.47
125.61
76.89
45.72
35.91
30.56
38.37
20.76
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.15
Current Assets
2,905.05
2,574.15
2,504.99
1,997.00
1,628.70
1,282.24
1,186.57
828.16
818.00
500.36
Current Investments
0.00
0.00
0.00
0.00
109.85
0.00
0.00
0.00
0.00
0.00
Inventories
1,300.55
1,149.41
978.55
782.18
438.43
384.21
279.95
269.18
253.72
224.52
Sundry Debtors
985.83
948.54
924.95
765.42
662.04
673.54
628.25
417.70
375.35
136.91
Cash & Bank
386.38
312.79
409.46
271.04
283.94
89.04
115.64
49.80
130.29
65.31
Other Current Assets
232.28
49.22
61.67
50.74
134.43
135.45
162.73
91.49
58.65
73.63
Short Term Loans & Adv.
186.00
114.19
130.35
127.61
91.83
98.46
114.09
51.66
48.68
2.05
Net Current Assets
822.75
760.65
863.38
823.90
735.30
385.76
308.65
41.03
163.25
85.33
Total Assets
5,483.88
4,903.14
4,511.53
3,712.68
3,223.11
2,978.58
2,670.28
1,878.71
1,562.97
1,202.72

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
439.41
738.75
332.06
432.48
476.19
262.24
-0.65
188.24
151.43
150.28
PBT
547.23
687.17
558.00
704.36
425.64
276.78
180.00
204.99
186.03
127.96
Adjustment
328.80
237.69
176.29
194.43
156.88
149.85
107.45
95.14
92.63
85.37
Changes in Working Capital
-246.32
-10.31
-257.19
-274.95
12.75
-75.94
-230.03
-52.37
-79.70
-31.34
Cash after chg. in Working capital
629.71
914.55
477.11
623.84
595.27
350.69
57.42
247.77
198.97
182.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-190.30
-175.80
-145.05
-191.37
-119.08
-88.45
-58.07
-59.53
-47.54
-31.72
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-360.16
-191.36
-380.12
-277.13
-160.63
-269.82
-462.31
-326.09
-161.65
-145.55
Net Fixed Assets
-101.04
-104.53
-302.61
-204.42
-124.57
-176.36
-282.01
-249.86
-75.62
-231.53
Net Investments
-264.87
-80.00
-5.00
-36.29
-48.78
-431.34
-0.01
13.84
-16.48
72.98
Others
5.75
-6.83
-72.51
-36.42
12.72
337.88
-180.29
-90.07
-69.55
13.00
Cash from Financing Activity
7.66
-440.29
190.00
-299.31
-212.85
-17.43
528.62
55.87
85.67
18.83
Net Cash Inflow / Outflow
86.92
107.10
141.94
-143.97
102.70
-25.01
65.66
-81.98
75.44
23.56
Opening Cash & Equivalents
291.56
184.71
41.84
185.93
83.02
108.03
42.37
124.35
54.85
41.75
Closing Cash & Equivalent
381.10
291.56
184.71
41.84
185.93
83.02
108.03
42.37
130.29
65.31

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
132.33
116.38
103.62
86.85
71.80
59.73
51.17
39.40
29.20
20.98
ROA
7.80%
10.97%
10.04%
15.84%
9.99%
6.64%
5.13%
8.12%
9.03%
8.31%
ROE
13.46%
19.18%
17.49%
27.64%
18.54%
13.32%
10.60%
18.23%
23.53%
23.29%
ROCE
15.66%
19.63%
17.37%
25.42%
17.22%
12.71%
11.09%
16.57%
20.16%
18.75%
Fixed Asset Turnover
1.42
1.66
1.63
1.97
1.75
1.78
1.55
1.59
1.66
1.77
Receivable days
78.34
75.78
81.94
65.94
83.34
100.03
112.83
100.84
67.60
33.47
Inventory Days
99.22
86.07
85.35
56.39
51.34
51.03
59.23
66.49
63.11
54.79
Payable days
138.29
112.38
114.29
117.79
58.20
54.96
62.37
64.87
59.99
53.57
Cash Conversion Cycle
39.26
49.48
52.99
4.54
76.48
96.10
109.70
102.46
70.72
34.69
Total Debt/Equity
0.38
0.38
0.43
0.39
0.49
0.65
0.75
0.73
1.01
1.14
Interest Cover
6.17
13.29
25.04
27.80
16.75
10.72
6.44
7.36
6.02
4.96

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Granules India reports 8% rise in Q4 consolidated net profit
    15th May 2024, 15:16 PM

    Total consolidated income of the company decreased by 1.77% at Rs 1,177.65 crore for Q4FY24

    Read More
  • Granules India - Quarterly Results
    15th May 2024, 12:33 PM

    Read More
  • Granules India’s arm gets USFDA’s approval for Colchicine Capsules
    30th Apr 2024, 10:50 AM

    Granules now have a total of 64 ANDA approvals from the USFDA

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.